ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 284915 for:    ALL

Platelet Antisedimentation Rate and Multiplate ex Vivo Examinations in Patients on Antiplatelet Therapy and Healthy Controls

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03679858
Recruitment Status : Recruiting
First Posted : September 20, 2018
Last Update Posted : September 20, 2018
Sponsor:
Information provided by (Responsible Party):
Tihamér Molnár, University of Pecs

Brief Summary:
To search for simple laboratory methods selecting patients with low/non-responsevness to P2Y12 receptor antagonists.

Condition or disease Intervention/treatment
Cerebrovascular Disorders Antiplatelet Therapy Other: Platelet function test

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Platelet Antisedimentation Rate and Multiplate ex Vivo Examinations in Cerebrovascular Patients Treated With Antiplatelet Therapy and Healthy Controls
Actual Study Start Date : January 1, 2018
Estimated Primary Completion Date : October 1, 2018
Estimated Study Completion Date : January 1, 2019

Group/Cohort Intervention/treatment
Platelet function test in patients
Platelet function test in patients on antiplatelet therapy
Other: Platelet function test
Ex vivo platelet aggregation analysis by Multiplate aggregometer

Platelet function test in healthy
Platelet function test in healthy subjects
Other: Platelet function test
Ex vivo platelet aggregation analysis by Multiplate aggregometer




Primary Outcome Measures :
  1. Major cerebrovascular event [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with cerebrovascular disorders on antiplatelet therapy as a secundary prevention.
Criteria

Inclusion Criteria:

  • Written informed consent

Exclusion Criteria:

  • Declined informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03679858


Contacts
Contact: Tihamer Molnar, MD, PhD +36302275814 tihamermolnar@yahoo.com

Locations
Hungary
University of Pécs Recruiting
Pécs, Baranya, Hungary, 7624
Contact: Erzsebet Ezer, MD    +36302882415    ezererzsebet@yahoo.com   
Contact: Lajos Bogar, MD, DSc    +36302889503    bogar.lajos@pte.hu   
Sponsors and Collaborators
University of Pecs
Investigators
Principal Investigator: Tihamer Molnar, MD, PhD University of Pécs Medical School

Additional Information:
Responsible Party: Tihamér Molnár, associate professor, University of Pecs
ClinicalTrials.gov Identifier: NCT03679858     History of Changes
Other Study ID Numbers: PTE6735
First Posted: September 20, 2018    Key Record Dates
Last Update Posted: September 20, 2018
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Individual participant's aggregometry data will be shared with other researchers.

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases